FDA News

Privosegtor Secures EMA PRIME Designation for Optic Neuritis Treatment

FDA · optic neuritis · 5 min

Arrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting

FDA · Cardiometabolic disorders · 6 min

Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma

FDA · 6 min

Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology

FDA · oncology · 6 min

AbbVie Plans Layoffs: Implications for the Pharma Industry

FDA · 6 min

EMA Approves Novo's Wegovy: A Game Changer in Weight Loss

FDA · 6 min

DEFINITIVE Trial Milestone: 50% Recruitment Achieved

FDA · oncology · 7 min

Quoin Pharmaceuticals Aims for First Peeling Skin Syndrome Trial with FDA IND Submission

FDA · 9 min

ASCO26: AstraZeneca's Camizestrant Data Aims to Sway FDA Approval

FDA · 8 min

OS Therapies' OST-HER2 Nears FDA Accelerated Approval for Osteosarcoma Amidst ASCO Data Presentation

FDA · osteosarcoma · 8 min

FDA Approves AstraZeneca's Imfinzi-BCG Combination for High-Risk NMIBC

FDA · NMIBC · 8 min

Datroway Priority Review Fuels Hope for Metastatic Triple-Negative Breast Cancer Patients

FDA · breast cancer · 7 min